Genetically Engineered Microorganisms and Their Impact on Human Health

被引:9
作者
Ari, Marzie Mahdizade [1 ,2 ]
Dadgar, Leila [1 ,2 ]
Elahi, Zahra [1 ,2 ]
Ghanavati, Roya [3 ]
Taheri, Behrouz [4 ]
机构
[1] Iran Univ Med Sci, Sch Med, Dept Microbiol, Tehran, Iran
[2] Iran Univ Med Sci, Microbial Biotechnol Res Ctr, Tehran, Iran
[3] Behbahan Fac Med Sci, Behbahan, Iran
[4] Ahvaz Jundishapour Univ Med Sci, Sch Med, Dept Orthopaed, Ahvaz, Iran
关键词
COLI NISSLE 1917; INFLAMMATORY-BOWEL-DISEASE; LACTIC-ACID BACTERIA; PHASE-I TRIAL; LACTOCOCCUS-LACTIS; BIFIDOBACTERIUM-LONGUM; COMMENSAL BACTERIUM; SALMONELLA-TYPHIMURIUM; BIOLOGICAL CONTAINMENT; ASPERGILLUS-NIDULANS;
D O I
10.1155/2024/6638269
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The emergence of antibiotic-resistant strains, the decreased effectiveness of conventional therapies, and the side effects have led researchers to seek a safer, more cost-effective, patient-friendly, and effective method that does not develop antibiotic resistance. With progress in synthetic biology and genetic engineering, genetically engineered microorganisms effective in treatment, prophylaxis, drug delivery, and diagnosis have been developed. The present study reviews the types of genetically engineered bacteria and phages, their impacts on diseases, cancer, and metabolic and inflammatory disorders, the biosynthesis of these modified strains, the route of administration, and their effects on the environment. We conclude that genetically engineered microorganisms can be considered promising candidates for adjunctive treatment of diseases and cancers.
引用
收藏
页数:38
相关论文
共 289 条
  • [61] Receptor-targeted engineered probiotics mitigate lethal Listeria infection
    Drolia, Rishi
    Amalaradjou, Mary Anne Roshni
    Ryan, Valerie
    Tenguria, Shivendra
    Liu, Dongqi
    Bai, Xingjian
    Xu, Luping
    Singh, Atul K.
    Cox, Abigail D.
    Bernal-Crespo, Victor
    Schaber, James A.
    Applegate, Bruce M.
    Vemulapalli, Ramesh
    Bhunia, Arun K.
    [J]. NATURE COMMUNICATIONS, 2020, 11 (01)
  • [62] Secretion of Insulinotropic Proteins by Commensal Bacteria: Rewiring the Gut To Treat Diabetes
    Duan, Faping
    Curtis, Katherine L.
    March, John C.
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2008, 74 (23) : 7437 - 7438
  • [63] Engineered Commensal Bacteria Reprogram Intestinal Cells Into Glucose-Responsive Insulin-Secreting Cells for the Treatment of Diabetes
    Duan, Franklin F.
    Liu, Joy H.
    March, John C.
    [J]. DIABETES, 2015, 64 (05) : 1794 - 1803
  • [64] ORAL VACCINATION WITH AN ATTENUATED SALMONELLA-TYPHIMURIUM STRAIN EXPRESSING BORRELIA-BURGDORFERI OSPA PREVENTS MURINE LYME BORRELIOSIS
    DUNNE, M
    ALRAMADI, BK
    BARTHOLD, SW
    FLAVELL, RA
    FIKRIG, E
    [J]. INFECTION AND IMMUNITY, 1995, 63 (04) : 1611 - 1614
  • [65] Genetically engineered probiotic for the treatment of phenylketonuria (PKU); assessment of a novel treatment in vitro and in the PAHenu2 mouse model of PKU
    Durrer, Katherine E.
    Allen, Michael S.
    von Herbing, Ione Hunt
    [J]. PLOS ONE, 2017, 12 (05):
  • [66] Magnetic resonance imaging of tumor necrosis
    Egeland, Tormod A. M.
    Gaustad, Jon-Vidar
    Galappathi, Kanthi
    Rofstad, Einar K.
    [J]. ACTA ONCOLOGICA, 2011, 50 (03) : 427 - 434
  • [67] Elen Aquino P., 2011, Progress in Molecular and Environmental Bioengineering
  • [68] The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infection
    Faghihkhorasani, Amirhosein
    Ahmed, Hanan Hassan
    Mashool, Noor Muhammad
    Alwan, Mariem
    Assefi, Marjan
    Adab, Aya Hussein
    Yasamineh, Saman
    Gholizadeh, Omid
    Baghani, Moein
    [J]. VIROLOGY JOURNAL, 2023, 20 (01)
  • [69] Impact of Nanotechnology on Drug Delivery
    Farokhzad, Omid C.
    Langer, Robert
    [J]. ACS NANO, 2009, 3 (01) : 16 - 20
  • [70] Efficient treatment of a preclinical inflammatory bowel disease model with engineered bacteria
    Ferenczi, Szilamer
    Solymosi, Norbert
    Horvath, Istvan
    Szeocs, Natalia
    Grozer, Zsuzsanna
    Kuti, Daniel
    Juhasz, Balazs
    Winkler, Zsuzsanna
    Pankotai, Tibor
    Sukosd, Farkas
    Stagel, Aniko
    Paholcsek, Melinda
    Dora, David
    Nagy, Nandor
    Kovacs, Krisztina J.
    Zanoni, Ivan
    Szallasi, Zoltan
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 20 : 218 - 226